Upregulated expression of TIM-3 in tumor tissue samples has been demonstrated in melanoma, prostate cancer, colon cancer, bladder urothelial carcinoma, cervical cancer, gastric cancer, liver cancer, and lung cancer cells. The gene discussed is HAVCR2; the disease is liver cancer.